Cite
HARVARD Citation
Groothof, D. et al. (2022). Letter by Groothof et al Regarding Article, "Efpeglenatide and Clinical Outcomes With and Without Concomitant Sodium-Glucose Cotransporter-2 Inhibition Use in Type 2 Diabetes: Exploratory Analysis of the AMPLITUDE-O Trial". Circulation. 146 (2), pp. e5-e6. [Online].